E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/22/2009 in the Prospect News Special Situations Daily.

Symmetry Medical shareholder Blum Capital reduces interest to 4.1%

By Lisa Kerner

Charlotte, N.C., Oct. 22 - A group of Symmetry Medical, Inc. investors led by Blum Capital Partners, LP sold 882,919 shares of the company's stock in open-market transactions on Oct. 19 through Oct. 21 at prices from $9.88 to $9.91 each, according to a schedule 13D/A filed with the Securities and Exchange Commission on Thursday.

On Oct. 14 through Oct. 16, Blum sold 404,985 shares priced from $9.90 to $10.42 each for a 6.6% stake, a prior SEC filing said.

Blum beneficially owns 1,472,400 shares, or 4.1%, of the Warsaw, Ind.-based surgical instruments and products company's outstanding stock.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.